Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unprecedented long-term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo- and immunotherapeutic regimens.
Cerbone L, Delfanti S, De Angelis AM, Crivellari S, Boccuzzi F, Cimorelli A, Bertolotti M, Righi L, Bertino P, Grosso F. Cerbone L, et al. Among authors: bertino p. Thorac Cancer. 2023 Feb;14(5):524-527. doi: 10.1111/1759-7714.14789. Epub 2023 Jan 4. Thorac Cancer. 2023. PMID: 36599413 Free PMC article.
Fowlpox-based survivin vaccination for malignant mesothelioma therapy.
Bertino P, Panigada M, Soprana E, Bianchi V, Bertilaccio S, Sanvito F, Rose AH, Yang H, Gaudino G, Hoffmann PR, Siccardi A, Carbone M. Bertino P, et al. Int J Cancer. 2013 Aug 1;133(3):612-23. doi: 10.1002/ijc.28048. Epub 2013 Feb 25. Int J Cancer. 2013. PMID: 23335100 Free PMC article.
Chemotherapy of malignant pleural mesothelioma.
Bertino P, Carbone M, Pass H. Bertino P, et al. Expert Opin Pharmacother. 2009 Jan;10(1):99-107. doi: 10.1517/14656560802631285. Expert Opin Pharmacother. 2009. PMID: 19236184 Review.
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models.
Hoffmann PR, Hoffmann FW, Premeaux TA, Fujita T, Soprana E, Panigada M, Chew GM, Richard G, Hindocha P, Menor M, Khadka VS, Deng Y, Moise L, Ndhlovu LC, Siccardi A, Weinberg AD, De Groot AS, Bertino P. Hoffmann PR, et al. Among authors: bertino p. Front Oncol. 2019 Aug 2;9:720. doi: 10.3389/fonc.2019.00720. eCollection 2019. Front Oncol. 2019. PMID: 31428586 Free PMC article.
Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma.
Catassi A, Paleari L, Servent D, Sessa F, Dominioni L, Ognio E, Cilli M, Vacca P, Mingari M, Gaudino G, Bertino P, Paolucci M, Calcaterra A, Cesario A, Granone P, Costa R, Ciarlo M, Alama A, Russo P. Catassi A, et al. Among authors: bertino p. Eur J Cancer. 2008 Oct;44(15):2296-311. doi: 10.1016/j.ejca.2008.06.045. Epub 2008 Aug 20. Eur J Cancer. 2008. PMID: 18722110
Preclinical development of HIvax: Human survivin highly immunogenic vaccines.
Hoffmann PR, Panigada M, Soprana E, Terry F, Bandar IS, Napolitano A, Rose AH, Hoffmann FW, Ndhlovu LC, Belcaid M, Moise L, De Groot AS, Carbone M, Gaudino G, Matsui T, Siccardi A, Bertino P. Hoffmann PR, et al. Among authors: bertino p. Hum Vaccin Immunother. 2015;11(7):1585-95. doi: 10.1080/21645515.2015.1050572. Hum Vaccin Immunother. 2015. PMID: 26042612 Free PMC article.
Erionite exposure in North Dakota and Turkish villages with mesothelioma.
Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, Pass HI, Rivera ZS, Steele I, Tuncer M, Way S, Yang H, Miller A. Carbone M, et al. Among authors: bertino p. Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13618-23. doi: 10.1073/pnas.1105887108. Epub 2011 Jul 25. Proc Natl Acad Sci U S A. 2011. PMID: 21788493 Free PMC article.
33 results